Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Phio (NASDAQ: PHIO) Names David H. Deming Lead Independent Director, with over 30 Years

Summary by stocktitan.net
Phio appoints David H. Deming as lead independent director. He spent over 27 years at JP Morgan, 12 leading its Health Group, and joined the Board in Feb 2025.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

Kingston Whig-StandardKingston Whig-Standard

Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director

King of Prussia, Pennsylvania--(Newsfile Corp. - October 31, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA

·Kingston, Canada
Read Full Article
stocktitan.netstocktitan.net

Phio (NASDAQ: PHIO) names David H. Deming lead independent director, with over 30 years

Phio appoints David H. Deming as lead independent director. He spent over 27 years at JP Morgan, 12 leading its Health Group, and joined the Board in Feb 2025.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Friday, October 31, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

King of Prussia icon

King of Prussia

News
For You
SearchBlindspotLocal